--- title: "Biogen (BIIB.US) — 财务报表" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/BIIB.US/norm.md" symbol: "BIIB.US" name: "Biogen" parent: "https://longbridge.com/zh-CN/quote/BIIB.US.md" datetime: "2026-05-20T00:38:27.069Z" locales: - [en](https://longbridge.com/en/quote/BIIB.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/BIIB.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/BIIB.US/norm.md) --- # Biogen (BIIB.US) — 财务报表 ## 利润表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 每股收益 | 2.15 | -0.3333 | 3.17 | 4.33 | 1.64 | | ROE | 6.93% | -1.07% | 10.41% | 14.67% | 5.71% | | 营业收入 | 2.48B | 2.28B | 2.53B | 2.65B | 2.43B | | 净利润 | 319.50M | -48.90M | 466.50M | 634.80M | 240.50M | | 营业利润 | 567.40M | 447.70M | 778.60M | 915.60M | 676.60M | | 毛利率 | 75.37% | 80.55% | 79.93% | 64.23% | 76.23% | | 净利率 | 12.89% | -2.15% | 18.40% | 24.00% | 9.89% | | 利润含金量 | 87.90% | 87.46% | 61.19% | 569.05% | 260.93% | ## 资产负债表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 资产与负债 | 29.48B | 29.44B | 29.21B | 28.33B | 28.03B | | 权益乘数 | 1.58 | 1.61 | 1.60 | 1.61 | 1.65 | | 每股净资产 | 126.37 | 124.37 | 124.11 | 120.29 | 115.90 | | 资产周转率 | 0.3456 | 0.3441 | 0.3500 | 0.3626 | 0.3596 | | 现金及短投 | 4.28B | 3.82B | 3.96B | 2.76B | 2.60B | | 存货与应收 | 1.95B | 2.17B | 2.21B | 2.27B | 2.27B | | 长期投资 | 3.27B | 3.32B | 3.41B | 3.43B | 3.48B | | 净债务 | 1.81B | 2.41B | 2.63B | 3.84B | 4.02B | ## 现金流量表 (USD) | 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | | --- | --- | --- | --- | --- | --- | | 经营现金流 | 645.50M | 511.90M | 1.27B | 160.90M | 259.30M | | 投资现金流 | -209.50M | -1.23B | -35.10M | -57.00M | -47.30M | | 融资现金流 | -43.80M | -137.00M | -130.20M | -11.70M | -23.00M | | 自由现金流 | 537.42M | 226.51M | 1.05B | 269.05M | 548.58M | | 现金流充裕率 | 1260.74% | 158.04% | 2754.33% | 9.06% | 698.92% | | 举债与偿债 | - | 0.0000 | -300000.00 | 1.73B | - | | 资本支出 | -51.20M | -43.90M | -46.20M | -26.60M | -37.10M |